Pliant is executing cost reduction initiatives to prepare for the advancement of late-stage clinical trials. This strategic move aims to improve efficiency and streamline operations as the company progresses towards the next phase of development. The focus is on increasing profitability and optimizing resources for the successful execution of upcoming trials.